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resources for treatment in order to provide not only optimal quality 
of life for patients, but also to garner additional information with 
the intent of minimizing what at present are severe consequences 
of both the disease and its treatment.
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Craniopharyngiomas are rare embryogenic malformations of the 
sellar area with low-grade histological malignancy. Despite high 
survival rates (87–95% in recent series), quality of life is frequently 
impaired in long-term survivors due to sequelae caused by the ana-
tomical proximity of the tumor to the optic nerve, pituitary gland, 
and hypothalamus – in many cases even entanglement with the hypo-
thalamus (Cohen et al., 2011; Müller, 2011; Zoicas and Schöfl, 2012). 
One of the most serious quality of life complications of craniophar-
yngioma is hypothalamic obesity or so-called “hypothalamic syn-
drome,” a problem that can manifest before and/or after treatment. 
Novel insights into mechanisms of neuroendocrine satiety regulation 
and the pathogenic relevance of the autonomous nervous system are 
expected to facilitate future therapeutic approaches for hypothalamic 
syndrome (Elfers and Roth, 2011; Lustig, 2011; Roth, 2011).
For the time being, current treatment options for craniopharyn-
gioma patients suffering from hypothalamic syndrome are limited, 
the most effective to date being bariatric surgery. Bariatric surgery 
is tolerable and effective in weight-reduction for severely obese 
adult craniopharyngioma patients (Bingham et al., 2012), but con-
sidered intrusive and therefore controversial for younger patients. 
A substantial improvement in prognosis of craniopharyngioma 
will require the development of risk adapted neurosurgical (Flitsch 
et al., 2011; Bartels et al., 2012; Puget, 2012; Trippel and Nikkhah, 
2012) and radiooncological (Kortmann, 2011) treatment strategies 
in a multidisciplinary approach. Recent multicenter cooperation 
in this area has already led to beneficial results.
The consequences of both the surgical treatment and post-sur-
gical management of the disease are as complicated and hypotha-
lamic-intertwined as the tumors themselves. Risk adapted surgical 
strategies at initial diagnosis should aim at a maximal degree of 
resection, respecting the integrity of optical and hypothalamic 
structures in order to prevent severe sequelae and therein mini-
mize consequences that could negatively exacerbate patient quality 
of life. Because initial hypothalamic tumor involvement typically 
has an a priori, life-long effect on the clinical course (Müller, 2011) 
experienced by the patient, childhood, and adult onset crani-
opharyngioma should be recognized as chronic diseases requiring 
 constant monitoring of the consequences and developing medical 
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